Rocuronium + Sugammadex vs. Succinylcholine + Cisatracurium + Neostigmine/Atropine in Obese Participants (MK-8616-104)

NCT02410590 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Neuromuscular Blockade

Interventions

DRUG: Rocuronium
DRUG: Sugammadex
DRUG: Cisatracurium
DRUG: Neostigmine/Atropine
DRUG: Succinylcholine

Sponsor

Merck Sharp & Dohme LLC